...
首页> 外文期刊>Clinical and experimental pharmacology & physiology >OXIDATIVE STRESS AND CARDIOVASCULAR DISEASE: PATIENTS, GENOMES AND PATHWAYS
【24h】

OXIDATIVE STRESS AND CARDIOVASCULAR DISEASE: PATIENTS, GENOMES AND PATHWAYS

机译:氧化应激和心血管疾病:患者,基因组和途径

获取原文
获取原文并翻译 | 示例

摘要

The majority of modifiable cardiovascular risk factors are complex, polygenic or at least oligogenic traits, with genetic and environmental determinants playing an important role in disease risk and its pheno-typic expression. The Human Genome Project and subsequent mouse and rat genome data have provided powerful tools to commence the dissection of genetic determinants of hypertension and other cardiovascular risk factors. Despite several new methodologies such as genome-wide scans, genome-wide gene expression profiling and proteomic screens, it is fair to say that the progress of genetic studies designed as non-hypothesis driven, has been relatively slow. On the other hand, several interesting candidate a pathways have been identified, where investigators allowed for hypothesis driven functional studies. One example of such pathway is vascular oxidative stress, with its extensive network of genes and proteins, many with proven contributions to cardiovascular disease. Therefore, in parallel to genome-or proteome-wide studies, it will be constructive to pursue "pathway-omics", defined here as functional studies of a candidate pathway for disease pathogenesis.
机译:大多数可改变的心血管危险因素是复杂的,多基因的或至少是寡聚的,遗传和环境决定因素在疾病风险及其表型表达中起重要作用。人类基因组计划以及随后的小鼠和大鼠基因组数据提供了强大的工具,可以开始剖析高血压和其他心血管危险因素的遗传决定因素。尽管有几种新的方法,例如全基因组扫描,全基因组基因表达谱分析和蛋白质组学筛查,可以说,以非假设驱动的基因研究进展相对缓慢。另一方面,已经确定了几种有趣的候选a途径,研究人员在其中进行了假设驱动的功能研究。这种途径的一个例子是血管氧化应激,它具有广泛的基因和蛋白质网络,其中许多已被证明对心血管疾病有贡献。因此,与全基因组或蛋白质组范围的研究并行,追求“通路组学”(在此定义为疾病发病机理的候选途径的功能研究)将具有建设性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号